THE PRODUCT OF THE EMS1 GENE, AMPLIFIED AND OVEREXPRESSED IN HUMAN CARCINOMAS, IS HOMOLOGOUS TO A V-SRC SUBSTRATE AND IS LOCATED IN CELL-SUBSTRATUM CONTACT SITES
E. Schuuring et al., THE PRODUCT OF THE EMS1 GENE, AMPLIFIED AND OVEREXPRESSED IN HUMAN CARCINOMAS, IS HOMOLOGOUS TO A V-SRC SUBSTRATE AND IS LOCATED IN CELL-SUBSTRATUM CONTACT SITES, Molecular and cellular biology, 13(5), 1993, pp. 2891-2898
We have previously identified two genes (EMS1 and PRAD1/cyclin D1) in
the chromosome 11q13 region that are frequently coamplified and overex
pressed in human breast cancer and in squamous cell carcinomas of the
head and neck (E. Schuuring, E. Verhoeven, W. J. Mooi, and R. J. A. M.
Michalides, Oncogene 7:355-361, 1992). We now report on the character
ization of the 80/85-kDa protein that is encoded by the EMS] gene. Ami
no acid sequence comparison shows a high homology (85%) to a chicken p
rotein that was recently identified as a substrate for the src oncogen
e (H. Wu, A. B. Reynolds, S. B. Kanner, R. R. Vines, and J. T. Parsons
, Mol. Cell. Biol. 11:5113-5124, 1991). Immunocytochemistry reveals th
at in epithelial cells, the human EMS1 protein is localized mainly in
the cytoplasm and, to a very low extent, in protruding leading lamella
e of the cell. However, in carcinoma cells that constitutively overexp
ress the protein as a result of amplification of the EMS1 gene, the pr
otein, except in cytoplasm, accumulates in the podosome-like adherens
junctions associated with the cell-substratum contact sites. The prote
in was not found in intercellular adherens junctions. Our findings, an
d the previously reported observations in src-transformed chicken embr
yo fibroblasts, suggest that the EMS1 protein is involved in regulatin
g the interactions between components of adherens-type junctions. Sinc
e amplification of the 11q13 region has been associated with an enhanc
ed invasive potential of these tumors, overexpression and concomitant
accumulation of the EMS1 protein in the cell-substratum contact sites
might, therefore, contribute to the invasive potential of these tumor
cells.